MHRA deepens global strategy with Singapore regulatory pathway

MHRA is deepening its collaborative push with a new “regulatory innovation corridor” created jointly with Singapore’s Health Sciences Authority (HSA), giving companies earlier and more coordinated access to scientific advice across the two agencies. The scheme launched with a high-profile endorsement: Flagship Pioneering will be its first industry partner, giving its portfolio companies a direct pathway to joint regulatory engagement.

Since its break from EMA following the U.K.’s exit from the EU in 2019, MHRA has sought to work with trusted regulatory partners abroad to bolster its standing as a top-tier global regulator, while also supporting the strengths of the U.K.’s life sciences sector...